Literature DB >> 22030238

Butyrophilins: an emerging family of immune regulators.

Lucie Abeler-Dörner1, Mahima Swamy, Gareth Williams, Adrian C Hayday, Anna Bas.   

Abstract

Butyrophilins (Btns) and butyrophilin-like (Btnl) molecules are emerging as novel regulators of immune responses in mice and humans. Several clues point to their probable importance: many of the genes are located within the MHC; they are structurally related to B7-co-stimulatory molecules; they are functionally implicated in T cell inhibition and in the modulation of epithelial cell-T cell interactions; and they are genetically associated with inflammatory diseases. Nonetheless, initial immersion into the current literature can uncover confusion over even basic information such as gene names and expression patterns, and seemingly conflicting data regarding the biological activities of different family members. This review addresses each of these issues, concluding with the attractive potential of Btn and Btnl molecules to act as specific attenuators of tissue-associated inflammatory responses.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030238     DOI: 10.1016/j.it.2011.09.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  60 in total

1.  Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells.

Authors:  Dieter Kabelitz
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

Review 2.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

3.  BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.

Authors:  Xiaohong Tian; Yujun Lin; Cheng Cui; Min Su; Laijun Lai
Journal:  Adv Healthc Mater       Date:  2019-03-18       Impact factor: 9.933

4.  Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.

Authors:  Siyi Gu; Joseph R Sachleben; Christopher T Boughter; Wioletta I Nawrocka; Marta T Borowska; Jeffrey T Tarrasch; Georgios Skiniotis; Benoît Roux; Erin J Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 5.  Immune modulation by butyrophilins.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

6.  Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.

Authors:  Rebekah R Shippy; Xiaochen Lin; Sherry S Agabiti; Jin Li; Brendan M Zangari; Benjamin J Foust; Michael M Poe; Chia-Hung Christine Hsiao; Olga Vinogradova; David F Wiemer; Andrew J Wiemer
Journal:  J Med Chem       Date:  2017-03-01       Impact factor: 7.446

7.  Milk lipid secretion: recent biomolecular aspects.

Authors:  James L McManaman
Journal:  Biomol Concepts       Date:  2012-12-01

8.  ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.

Authors:  Chi-Fen Chen; Rolando Ruiz-Vega; Priya Vasudeva; Francisco Espitia; Tatiana B Krasieva; Sebastien de Feraudy; Bruce J Tromberg; Sharon Huang; Chad P Garner; Jie Wu; Dave S Hoon; Anand K Ganesan
Journal:  Cell Rep       Date:  2017-03-07       Impact factor: 9.423

9.  Skint8, a Novel B7 Family-Related Molecule, Negatively Regulates T Cell Responses.

Authors:  Yujun Lin; Cheng Cui; Min Su; Xiaohong Tian; Yuanmao Huang; Jin Zhao; Laijun Lai
Journal:  J Immunol       Date:  2019-06-12       Impact factor: 5.422

10.  BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.

Authors:  Kyle K Payne; Jessica A Mine; Subir Biswas; Ricardo A Chaurio; Alfredo Perales-Puchalt; Carmen M Anadon; Tara Lee Costich; Carly M Harro; Jennifer Walrath; Qianqian Ming; Evgenii Tcyganov; Andrea L Buras; Kristen E Rigolizzo; Gunjan Mandal; Jason Lajoie; Michael Ophir; Julia Tchou; Douglas Marchion; Vincent C Luca; Piotr Bobrowicz; Brooke McLaughlin; Ugur Eskiocak; Michael Schmidt; Juan R Cubillos-Ruiz; Paulo C Rodriguez; Dmitry I Gabrilovich; Jose R Conejo-Garcia
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.